Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Glutamyl Aminopeptidase - Pipeline Review, H2 2016 - Key Vendors are APAvadis Biotechnologies & Quantum Genomics - Research and Markets

Research and Markets
Posted on: 27 Oct 16

Research and Markets has announced the addition of the "Glutamyl Aminopeptidase (EAP or Aminopeptidase A or Differentiation Antigen gp160 or CD249 or ENPEP or EC - Pipeline Review, H2 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Glutamyl Aminopeptidase, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Glutamyl Aminopeptidase and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Mentioned:

  • APAvadis Biotechnologies Srl
  • Quantum Genomics SA

Key Topics Covered:

  1. Introduction
  2. Glutamyl Aminopeptidase Overview
  3. Therapeutics Development
  4. Pipeline Products for Glutamyl Aminopeptidase - Overview
  5. Pipeline Products for Glutamyl Aminopeptidase - Comparative Analysis
  6. Glutamyl Aminopeptidase - Therapeutics under Development by Companies
  7. Glutamyl Aminopeptidase - Therapeutics under Investigation by Universities/Institutes
  8. Glutamyl Aminopeptidase - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Glutamyl Aminopeptidase - Products under Development by Companies
  13. Glutamyl Aminopeptidase - Products under Investigation by Universities/Institutes
  14. Glutamyl Aminopeptidase - Companies Involved in Therapeutics Development

For more information about this report visit

View source version on

Business Wire

Last updated on: 27/10/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.